Abstract 475: Combinational treatment with MUC1 vaccine and Indomethacin reduces breast tumor burden via a COX-independent pathway.
Jennifer M. Curry(University of North Carolina at Charlotte), Pinku Mukherjee(University of North Carolina at Charlotte), Shanti Rao(University of North Carolina at Charlotte), Lopamudra Das Roy(University of North Carolina at Charlotte), Sritama Nath(University of North Carolina at Charlotte), Dahlia M. Besmer(University of North Carolina at Charlotte), Priyanka Grover(University of North Carolina at Charlotte)
Cited by 1
Related Papers
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
|Pharmacology & Therapeutics|2016|921
MUC1: a multifaceted oncoprotein with a key role in cancer progression
|Trends in Molecular Medicine|2014|854
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
|Oncogene|2010|269
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
|Oncogenesis|2013|176
MUC1 regulates PDGFA expression during pancreatic cancer progression
|Oncogene|2012|86